ZANETTI, ELISA
ZANETTI, ELISA
Personale tecnico amm.vo
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling
2023 Gobbi G.; Grieco A.; Torricelli F.; Sauta E.; Santandrea G.; Zanetti E.; Fantini V.; Reggiani F.; Strocchi S.; Paci M.; Vohra M.; Saladi S.V.; Ambrosetti D.C.; Ciarrocchi A.; Sancisi V.
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes
2022 Palicelli A.; Croci S.; Bisagni A.; Zanetti E.; De Biase D.; Melli B.; Sanguedolce F.; Ragazzi M.; Zanelli M.; Chaux A.; Canete-Portillo S.; Bonasoni M.P.; Ascani S.; De Leo A.; Giordano G.; Landriscina M.; Carrieri G.; Cormio L.; Gandhi J.; Nicoli D.; Farnetti E.; Piana S.; Tafuni A.; Bonacini M.
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
2021 Reggiani F.; Sauta E.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V.
Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer
2021 Sauta E.; Reggiani F.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Strocchi S.; Paci M.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V.
Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study
2019 Kuhn E.; Ragazzi M.; Ciarrocchi A.; Torricelli F.; de Biase D.; Zanetti E.; Bisagni A.; Corrado S.; Uccella S.; La Rosa S.; Bongiovanni M.; Losito S.; Piana S.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling | Gobbi G.; Grieco A.; Torricelli F.; Sauta E.; Santandrea G.; Zanetti E.; Fantini V.; Reggiani F.;... Strocchi S.; Paci M.; Vohra M.; Saladi S.V.; Ambrosetti D.C.; Ciarrocchi A.; Sancisi V. | 2023-01-01 | CELL DEATH & DISEASE | - | 1.01 Articolo in rivista | s41419-023-06277-y.pdf; 41419_2023_6277_MOESM1_ESM.pdf; 41419_2023_6277_MOESM2_ESM.xlsx; 41419_2023_6277_MOESM3_ESM.xlsx; 41419_2023_6277_MOESM4_ESM.pdf |
| What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes | Palicelli A.; Croci S.; Bisagni A.; Zanetti E.; De Biase D.; Melli B.; Sanguedolce F.; Ragazzi M....; Zanelli M.; Chaux A.; Canete-Portillo S.; Bonasoni M.P.; Ascani S.; De Leo A.; Giordano G.; Landriscina M.; Carrieri G.; Cormio L.; Gandhi J.; Nicoli D.; Farnetti E.; Piana S.; Tafuni A.; Bonacini M. | 2022-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-10-00236-v3.pdf |
| An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma | Reggiani F.; Sauta E.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Damia G....; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V. | 2021-01-01 | MOLECULAR CANCER | - | 1.01 Articolo in rivista | s12943-021-01357-z.pdf |
| Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer | Sauta E.; Reggiani F.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Strocch...i S.; Paci M.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-03477.pdf |
| Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study | Kuhn E.; Ragazzi M.; Ciarrocchi A.; Torricelli F.; de Biase D.; Zanetti E.; Bisagni A.; Corrado S....; Uccella S.; La Rosa S.; Bongiovanni M.; Losito S.; Piana S. | 2019-01-01 | MODERN PATHOLOGY | - | 1.01 Articolo in rivista | - |